Genetic variant linked to higher heart failure risk in children with myocarditis

Genetic variant linked to higher heart failure risk in children with myocarditis

[ad_1] A genetic variant is likely putting some children suffering with myocarditis – inflammation of the heart muscle – at higher risk of developing heart failure, which can be fatal, according to a study published today in Circulation Heart Failure. According to the study, 34.4% of the children who developed dilated cardiomyopathy after developing myocarditis…

Read More
AI-assisted ultrasounds greatly improve detection of congenital heart defects

AI-assisted ultrasounds greatly improve detection of congenital heart defects

[ad_1] Doctors in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai have become the first in New York City to implement an artificial intelligence (AI) tool that enhances ultrasounds on a large scale-resulting in earlier detection and better care for babies and families. Congenital heart defects, or conditions…

Read More
Targeted Chronic Myeloid Leukemia Drugs Show Divergent Cardiovascular Risk Profiles, JACC Cardio-Oncology State-of-the-Art Review Reports

Targeted Chronic Myeloid Leukemia Drugs Show Divergent Cardiovascular Risk Profiles, JACC Cardio-Oncology State-of-the-Art Review Reports

[ad_1] Targeted Chronic Myeloid Leukemia Drugs Show Divergent Cardiovascular Risk Profiles, JACC Cardio-Oncology State-of-the-Art Review Reports We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link

Read More
Exploring Catheter Ablation and Drug Therapy Strategies in Post-Myocardial Infarction (MI) Ventricular Tachyarrhythmias: MANTRA-VT Trial

Exploring Catheter Ablation and Drug Therapy Strategies in Post-Myocardial Infarction (MI) Ventricular Tachyarrhythmias: MANTRA-VT Trial

[ad_1] Exploring Catheter Ablation and Drug Therapy Strategies in Post-Myocardial Infarction (MI) Ventricular Tachyarrhythmias: MANTRA-VT Trial We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link

Read More
A Critical Prognostic Marker in Atherosclerotic Cardiovascular Disease, Reports JACC Advances

A Critical Prognostic Marker in Atherosclerotic Cardiovascular Disease, Reports JACC Advances

[ad_1] New-Onset Proteinuria (NOP) During Hospitalization: A Critical Prognostic Marker in Atherosclerotic Cardiovascular Disease, Reports JACC Advances We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link

Read More
Clinical Value of Coronary microvascular dysfunction (CMD) and Vasospastic Angina (VSA) Testing: JACC Advances November 2025

Clinical Value of Coronary microvascular dysfunction (CMD) and Vasospastic Angina (VSA) Testing: JACC Advances November 2025

[ad_1] Clinical Value of Coronary microvascular dysfunction (CMD) and Vasospastic Angina (VSA) Testing: JACC Advances November 2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link

Read More